1. Lung development and the pulmonary surfactant system: hormonal ifluences.
- Author
-
Hitchcock KR
- Subjects
- Animals, Cell Differentiation drug effects, Cyclic AMP metabolism, Drug Interactions, Glucocorticoids therapeutic use, Humans, Infant, Newborn, Lung drug effects, Pulmonary Alveoli metabolism, Pulmonary Surfactants analysis, Respiratory Distress Syndrome, Newborn prevention & control, Thyroid Hormones blood, Glucocorticoids pharmacology, Lung growth & development, Pulmonary Alveoli cytology, Pulmonary Surfactants biosynthesis, Thyroid Hormones pharmacology
- Abstract
The effect of hormones on developmental events is not a new area of scientific investigation. However, in the last decade, the developing lung has been the focus of an increasing amount of basic and applied research. Inadequate development of the newborn's respiratory system precludes extra-uterine existence; indeed, such respiratory inadequacy has been a leading cause of death in premature infants. Tremendous strides have been made in understanding the basic cell biology of the developing lung. Much has been learned about the source, composition, and function of pulmonary surfactant, a surface-active material produced by the lung and essential to alveolar stability. Deficient stores of this material is a major etiologic factor in the respiratory distress syndrome of the newborn (RDS). This fact, coupled with observations that certain hormones can accelerate lung development and the consequent availability of adequate stores of pulmonary surfactant, has led to a large body of literaturae dealing with the effects of hormones (and other agents) on lung development. It is the purpose of this literature review (1) to discuss the various kinds of investigations which have linked surfactant synthesis to the type II pulmonary epithelial cell; and (2) to review the current status of research dealing with the effects of glucocorticoids and thyroid hormones on lung maturation.
- Published
- 1980
- Full Text
- View/download PDF